Search

everythinglearnresearchcommunity

for

Search:↓

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Severe digestive issues in DRESS need early endoscopy for better treatment.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

A new hand-held light therapy device was found to be safe and effective for treating mild-to-moderate acne.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

COVID-19 and its vaccines can cause various skin issues due to viral effects, immune responses, and stress.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

A woman developed severe skin damage after using a blood thinner called low-molecular-weight heparin.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Understanding skin reactions to radiation has improved, helping to reduce injuries and prevent skin cancer.